高雄醫學大學圖書館 |

Language: English

Back

Defining optimal immunotherapies for...

Goode, Jamie.

Defining optimal immunotherapies for type 1 diabetes /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Defining optimal immunotherapies for type 1 diabetes // [editors, Gregory Bock and Jamie Goode].
other author:	Goode, Jamie.
corporate name:	WHO Expert Committee on Specifications for Pharmaceutical Preparations
Published:	Chichester, UK ;Wiley-Blackwell, : 2008.,
Description:	ix, 212 p. :ill. ; : 24 cm.;
Notes:	Papers from the Novartis Foundation Symposium on Defining optimal immunotherapies for type 1 diabetes, held at The Novartis Foundation, London, 11-12 July 2007.
Subject:	Diabetes - Congresses. - Immunotherapy -
ISBN:	9780470723258 (hbk.) :

Defining optimal immunotherapies for type 1 diabetes /
Defining optimal immunotherapies for type 1 diabetes /[editors, Gregory Bock and Jamie Goode]. - Chichester, UK ;Wiley-Blackwell,2008. - ix, 212 p. :ill. ;24 cm. - Novartis Foundation symposium ;292. - Novartis Foundation symposium ;251..

Papers from the Novartis Foundation Symposium on Defining optimal immunotherapies for type 1 diabetes, held at The Novartis Foundation, London, 11-12 July 2007.

Includes bibliographical references and indexes.

ISBN: 9780470723258 (hbk.) :NT5610Subjects--Topical Terms:

397601
Diabetes
--Immunotherapy--Congresses.

LC Class. No.: RC661.I55 / D44 2008

Dewey Class. No.: 616.46206

National Library of Medicine Call No.: W1 / NO9285 v.292 2008

Defining optimal immunotherapies for type 1 diabetes /
LDR:00968nam0 2200241 i 450 001 193161
008 091215b c 000 0 eng
020 $a 9780470723258 (hbk.) : $c NT5610
020 $a 0470723254 (hbk.)
035 $a (OCoLC)173499055
035 $a 0254544
040 $a KMU $d KMU
042 $a nlmcopyc
050 # 4 $a RC661.I55 $b D44 2008
060 0 0 $a W1 $b NO9285 v.292 2008
060 1 0 $a WK 815 $b S9895d 2008
082 0 4 $a 616.46206 $2 22
111 2 $2 97100 $a WHO Expert Committee on Specifications for Pharmaceutical Preparations $n (40th : $d 2005 : $c Geneva, Switzerland) $3 245178 $3 296241
245 1 0 $a Defining optimal immunotherapies for type 1 diabetes / $c [editors, Gregory Bock and Jamie Goode].
260 # $a Chichester, UK ; $a Hoboken, NJ : $c 2008. $b Wiley-Blackwell,
300 $a ix, 212 p. : $b ill. ; $c 24 cm.
490 0 $a Novartis Foundation symposium ; $v 292
500 $a Papers from the Novartis Foundation Symposium on Defining optimal immunotherapies for type 1 diabetes, held at The Novartis Foundation, London, 11-12 July 2007.
504 $a Includes bibliographical references and indexes.
650 # 0 $2 96060 $a Diabetes $x Immunotherapy $v Congresses. $3 397601
650 1 2 $2 96060 $a Diabetes Mellitus, Type 1 $x therapy $v Congresses. $3 397600
700 1 # $2 97000 $a Goode, Jamie. $3 248510
700 1 # $2 97000 $a Bock, Gregory. $3 248509
710 2 # $2 97100 $a Novartis Foundation. $3 248511
830 0 $a Novartis Foundation symposium ; $v 251. $3 396436
900 $c 到館:2009/07/17 $d 編目:2009/07/17